James Daly
Director/Board Member bij ACADIA PHARMACEUTICALS INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Mr. James M.
Daly is an Independent Director at Madrigal Pharmaceuticals, Inc., an Independent Non-Executive Director at argenx SE and an Independent Director at ACADIA Pharmaceuticals, Inc. He is on the Board of Directors at Madrigal Pharmaceuticals, Inc., argenx SE and ACADIA Pharmaceuticals, Inc. Mr. Daly was previously employed as an Independent Director by Bellicum Pharmaceuticals, Inc., an Independent Director by Halozyme Therapeutics, Inc., an Independent Director by Chimerix, Inc., a Chief Commercial Officer & Executive VP by Incyte Corp., a Senior Vice President by Amgen Ventures LLC, a SVP-Global Marketing & Commercial Development by Amgen, Inc., a Senior Vice President-Respiratory Division by Smithkline Beecham Corp., and a Principal by Francis Cauffman, Inc. He also served on the board at Coherus BioSciences, Inc. He received his undergraduate degree from State University of New York at Buffalo and an MBA from State University of New York at Buffalo.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
14-08-2023 | 20 503 ( 0.02% ) | 834 062 $ | 31-03-2024 | |
01-06-2023 | 18 002 ( 0.01% ) | 332 857 $ | 31-03-2024 | |
02-04-2024 | 1 198 ( 0.01% ) | 319 914 $ | 31-03-2024 | |
ARGEN-X SE
0.00% | 20-02-2024 | 450 ( 0.00% ) | 177 925 $ | 31-03-2024 |
Actieve functies van James Daly
Bedrijven | Functie | Begin |
---|---|---|
ACADIA PHARMACEUTICALS INC. | Director/Board Member | 11-01-2016 |
ARGENX SE | Director/Board Member | 08-05-2018 |
MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 27-06-2019 |
Eerdere bekende functies van James Daly
Bedrijven | Functie | Einde |
---|---|---|
BELLICUM PHARMACEUTICALS, INC. | Director/Board Member | 23-02-2024 |
HALOZYME THERAPEUTICS, INC. | Director/Board Member | 31-12-2023 |
CHIMERIX, INC. | Director/Board Member | 21-02-2020 |
INCYTE CORPORATION | Corporate Officer/Principal | 26-06-2015 |
AMGEN INC. | Corporate Officer/Principal | - |
Opleiding van James Daly
State University of New York at Buffalo | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 8 |
---|---|
AMGEN INC. | Health Technology |
INCYTE CORPORATION | Health Technology |
ACADIA PHARMACEUTICALS INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
CHIMERIX, INC. | Health Technology |
ARGENX SE | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Amgen Ventures LLC
Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Finance |
Francis Cauffman, Inc.
Francis Cauffman, Inc. Engineering & ConstructionIndustrial Services Francis Cauffman, Inc. provides architecture, interior design, and planning services. The firm specializes in healthcare, science & technology and corporate. The company was founded by Hughes D. Cauffman, James Francis and George Wikinson in 1954 and is headquartered in New York, NY. | Industrial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |